An asymmetric synthesis of 3-aryl-1,4-oxazin-2-ones: Synthesis of a key intermediate of an NK1 receptor antagonist

Heterocycles

Volumn 58, Issue , 2002, Pages 119-123

  Devine, Paul N ^a   Foster, Bruce S ^a   Grabowski, Edward J J ^a   Reider, Paul J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXAZINE DERIVATIVE; SUBSTANCE P ANTAGONIST;

ARTICLE; CATALYSIS; CHIRALITY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

EID: 0037159786     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-02-s(m)54     Document Type: Article

References (24)

1. (a) C.-J. Chang, J.-M. Fang, G.-H. Lee, and Y. Wang, J. Chem. Soc., Perkin Trans. 1, 1994, 3587.
2. (b) L. S. Hegedus, G. Deweck, and S. Dandrea, J. Am. Chem. Soc., 1988, 110, 2122.
3. (c) M. S. Iyer, C. Yan, R. Kowalczyk, R. Shone, D. Ager, and D. R. Schaad, Synth. Commun., 1997, 27, 4355.
4. (d) M. P. Bertrand, L. Feray, R. Nouguier, and L. Stella, Synlett, 1998, 780.
5. (e) F. Polyak, T. Dorofeeva, G. Zelchans, and G. Shustov, Tetrahedron Lett., 1996, 37, 8223.
6. (a) R. M. Williams, P. J. Sinclair, D. Zhai, and D. Chen, J. Am. Chem. Soc., 1988, 110, 1547.
7. (b) Y. Aoyagi and R. M. Williams, Synlett, 1998, 1099.
8. (c) C. Agami, F. Couty, B. Prince, and C. Puchot, Tetrahedron, 1991, 47, 4343.
9. (d) H. Fretz, Tetrahedron, 1998, 54, 4849.
10. (e) J. D. Scott, T. N. Tippie, and R. M. Williams, Tetrahedron Lett., 1998, 39, 3659.
11. (a) C. Kashima and K. Harada, J. Chem. Soc., Perkin Trans. 1, 1988, 1521.
12. (b) M. S. Ashwood, I. F. Cottrell, and A. J. Davies, Tetrahedron Asymmetry, 1997, 8, 957.
13. M. A. Walker, Tetrahedron, 1997, 53, 14591.
14. P. N. Devine, U.-H. Dolling, R. M. Heid, and D. M. Tschaen, Tetrahedron Lett., 1996, 37, 2683.
15. P. N. Devine, R. M. Heid, and D. M. Tschaen, Tetrahedron, 1997, 53, 6739.
16. A. Le Rouzic, D. Ralphalen, and M. Kerfanto, C. R. Hebd. Seances Acad. Sci., 1979, 288, 221.
17. D. N. Harpp, C. J. Black, J. G. Gleason, and R. A. Smith, J. Org. Chem., 1975, 40, 3420.
18. 4), concentrated and purified via flash chromatography to yield 4.1 g (84%) of product as a viscous oil.
19. 3 (5%) followed by brine. The reaction was concentrated and purified via flash chromatography to give 0.18 g of oxazinone as a colorless solid.
20. 1 receptor antagonists see: (a) J. J. Hale, S. G. Mills, M. MacCoss, S. K. Shah, H. Qi, D. J. Mathre, M. A. Cascieri, S. Sadowski, C. D. Strader, D. E. MacIntyre, and J. M. Metzger, J. Med. Chem., 1996, 39, 1760. (b) J. J. Hale, S. G. Mills, M. MacCoss, P. E. Finke, M. A. Cascieri, S. Sadowski, E. Ber, G. G. Chicchi, M. Kurtz, J. Metzger, G. Eiermann, N. N. Tsou, F. D. Tatersall, M. N. J. Rupniak, A. R. Williams, W. Rycroft, R. Hargreaves, and D. E. Maclntyre, J. Med. Chem., 1998, 41, 4607. (c) C. J. Cowden, R. D. Wilson, B. C. Bishop, I. F. Cottrell, A. J. Davies, and U.-H. Dolling, Tetrahedron Lett., 2000, 41, 8661. (d) D. J. Wallace, J. M. Goodman, D. J. Kennedy, A. J. Davies, C. J. Cowden, M. S. Ashwood, I. F. Cottrell, U.-H. Dolling, and P. J. Reider, Org. Lett., 2001, 3, 671.
21. 1 receptor antagonists see: (a) J. J. Hale, S. G. Mills, M. MacCoss, S. K. Shah, H. Qi, D. J. Mathre, M. A. Cascieri, S. Sadowski, C. D. Strader, D. E. MacIntyre, and J. M. Metzger, J. Med. Chem., 1996, 39, 1760. (b) J. J. Hale, S. G. Mills, M. MacCoss, P. E. Finke, M. A. Cascieri, S. Sadowski, E. Ber, G. G. Chicchi, M. Kurtz, J. Metzger, G. Eiermann, N. N. Tsou, F. D. Tatersall, M. N. J. Rupniak, A. R. Williams, W. Rycroft, R. Hargreaves, and D. E. Maclntyre, J. Med. Chem., 1998, 41, 4607. (c) C. J. Cowden, R. D. Wilson, B. C. Bishop, I. F. Cottrell, A. J. Davies, and U.-H. Dolling, Tetrahedron Lett., 2000, 41, 8661. (d) D. J. Wallace, J. M. Goodman, D. J. Kennedy, A. J. Davies, C. J. Cowden, M. S. Ashwood, I. F. Cottrell, U.-H. Dolling, and P. J. Reider, Org. Lett., 2001, 3, 671.
22. 1 receptor antagonists see: (a) J. J. Hale, S. G. Mills, M. MacCoss, S. K. Shah, H. Qi, D. J. Mathre, M. A. Cascieri, S. Sadowski, C. D. Strader, D. E. MacIntyre, and J. M. Metzger, J. Med. Chem., 1996, 39, 1760. (b) J. J. Hale, S. G. Mills, M. MacCoss, P. E. Finke, M. A. Cascieri, S. Sadowski, E. Ber, G. G. Chicchi, M. Kurtz, J. Metzger, G. Eiermann, N. N. Tsou, F. D. Tatersall, M. N. J. Rupniak, A. R. Williams, W. Rycroft, R. Hargreaves, and D. E. Maclntyre, J. Med. Chem., 1998, 41, 4607. (c) C. J. Cowden, R. D. Wilson, B. C. Bishop, I. F. Cottrell, A. J. Davies, and U.-H. Dolling, Tetrahedron Lett., 2000, 41, 8661. (d) D. J. Wallace, J. M. Goodman, D. J. Kennedy, A. J. Davies, C. J. Cowden, M. S. Ashwood, I. F. Cottrell, U.-H. Dolling, and P. J. Reider, Org. Lett., 2001, 3, 671.
23. 1 receptor antagonists see: (a) J. J. Hale, S. G. Mills, M. MacCoss, S. K. Shah, H. Qi, D. J. Mathre, M. A. Cascieri, S. Sadowski, C. D. Strader, D. E. MacIntyre, and J. M. Metzger, J. Med. Chem., 1996, 39, 1760. (b) J. J. Hale, S. G. Mills, M. MacCoss, P. E. Finke, M. A. Cascieri, S. Sadowski, E. Ber, G. G. Chicchi, M. Kurtz, J. Metzger, G. Eiermann, N. N. Tsou, F. D. Tatersall, M. N. J. Rupniak, A. R. Williams, W. Rycroft, R. Hargreaves, and D. E. Maclntyre, J. Med. Chem., 1998, 41, 4607. (c) C. J. Cowden, R. D. Wilson, B. C. Bishop, I. F. Cottrell, A. J. Davies, and U.-H. Dolling, Tetrahedron Lett., 2000, 41, 8661. (d) D. J. Wallace, J. M. Goodman, D. J. Kennedy, A. J. Davies, C. J. Cowden, M. S. Ashwood, I. F. Cottrell, U.-H. Dolling, and P. J. Reider, Org. Lett., 2001, 3, 671.
24. R. J. Alabaster, A. W. Gibson, S. A. Johnson, J. S. Edwards and I. F. Cottrell, Tetrahedron Asymmetry, 1997, 8, 447.